These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31655172)

  • 1. Keratin 17 is a negative prognostic biomarker in high-grade endometrial carcinomas.
    Bai JDK; Babu S; Roa-Peña L; Hou W; Akalin A; Escobar-Hoyos LF; Shroyer KR
    Hum Pathol; 2019 Dec; 94():40-50. PubMed ID: 31655172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keratin 17 is overexpressed and predicts poor survival in estrogen receptor-negative/human epidermal growth factor receptor-2-negative breast cancer.
    Merkin RD; Vanner EA; Romeiser JL; Shroyer ALW; Escobar-Hoyos LF; Li J; Powers RS; Burke S; Shroyer KR
    Hum Pathol; 2017 Apr; 62():23-32. PubMed ID: 27816721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Keratin 17 identifies the most lethal molecular subtype of pancreatic cancer.
    Roa-Peña L; Leiton CV; Babu S; Pan CH; Vanner EA; Akalin A; Bandovic J; Moffitt RA; Shroyer KR; Escobar-Hoyos LF
    Sci Rep; 2019 Aug; 9(1):11239. PubMed ID: 31375762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keratin 17 testing in pancreatic cancer needle aspiration biopsies predicts survival.
    Roa-Peña L; Babu S; Leiton CV; Wu M; Taboada S; Akalin A; Buscaglia J; Escobar-Hoyos LF; Shroyer KR
    Cancer Cytopathol; 2021 Nov; 129(11):865-873. PubMed ID: 34076963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Keratin 17 is a sensitive and specific biomarker of urothelial neoplasia.
    Babu S; Mockler DC; Roa-Peña L; Szygalowicz A; Kim NW; Jahanfard S; Gholami SS; Moffitt R; Fitzgerald JP; Escobar-Hoyos LF; Shroyer KR
    Mod Pathol; 2019 May; 32(5):717-724. PubMed ID: 30443013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keratin 17 Is a Prognostic Biomarker in Endocervical Glandular Neoplasia.
    Mockler D; Escobar-Hoyos LF; Akalin A; Romeiser J; Shroyer AL; Shroyer KR
    Am J Clin Pathol; 2017 Sep; 148(3):264-273. PubMed ID: 28821199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of Musashi-1 in endometrioid adenocarcinoma.
    Ma L; Xu YL; Ding WJ; Shao HF; Teng YC
    Int J Clin Exp Pathol; 2015; 8(5):4564-72. PubMed ID: 26191146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of MMSET in endometrial cancer: a clinicopathologic study.
    Xiao M; Yang S; Chen J; Ning X; Guo L; Huang K; Sui L
    J Surg Oncol; 2013 Mar; 107(4):428-32. PubMed ID: 22886632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of neurotensin receptor 1 in endometrial adenocarcinoma is correlated with histological grade and clinical outcome.
    Agopiantz M; Forgez P; Casse JM; Lacomme S; Charra-Brunaud C; Clerc-Urmès I; Morel O; Bonnet C; Guéant JL; Vignaud JM; Gompel A; Gauchotte G
    Virchows Arch; 2017 Oct; 471(4):521-530. PubMed ID: 28836043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keratin 17 expression correlates with tumor progression and poor prognosis in gastric adenocarcinoma.
    Ide M; Kato T; Ogata K; Mochiki E; Kuwano H; Oyama T
    Ann Surg Oncol; 2012 Oct; 19(11):3506-14. PubMed ID: 22695933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of keratin 17 is associated with poor prognosis in epithelial ovarian cancer.
    Wang YF; Lang HY; Yuan J; Wang J; Wang R; Zhang XH; Zhang J; Zhao T; Li YR; Liu JY; Zeng LH; Guo GZ
    Tumour Biol; 2013 Jun; 34(3):1685-9. PubMed ID: 23430585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keratin 17 is a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma.
    Delgado-Coka LA; Roa-Peña L; Babu S; Horowitz M; Petricoin EF; Matrisian LM; Blais EM; Marchenko N; Allard FD; Akalin A; Jiang W; Larson BK; Hendifar AE; Picozzi VJ; Choi M; Shroyer KR; Escobar-Hoyos LF
    Am J Clin Pathol; 2024 Sep; 162(3):314-326. PubMed ID: 38642081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keratin-17 Promotes p27KIP1 Nuclear Export and Degradation and Offers Potential Prognostic Utility.
    Escobar-Hoyos LF; Shah R; Roa-Peña L; Vanner EA; Najafian N; Banach A; Nielsen E; Al-Khalil R; Akalin A; Talmage D; Shroyer KR
    Cancer Res; 2015 Sep; 75(17):3650-62. PubMed ID: 26109559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Keratin 17 Expression Predicts Poor Clinical Outcome in Patients With Advanced Esophageal Squamous Cell Carcinoma.
    Haye K; Babu S; Oblein L; Gupta R; Akalin A; Escobar-Hoyos LF; Shroyer KR
    Appl Immunohistochem Mol Morphol; 2021 Feb; 29(2):144-151. PubMed ID: 32554975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging Prognostic and Predictive Significance of Stress Keratin 17 in HPV-Associated and Non HPV-Associated Human Cancers: A Scoping Review.
    Lozar T; Wang W; Gavrielatou N; Christensen L; Lambert PF; Harari PM; Rimm DL; Burtness B; Grasic Kuhar C; Carchman EH
    Viruses; 2023 Nov; 15(12):. PubMed ID: 38140561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rictor is an independent prognostic factor for endometrial carcinoma.
    Wen SY; Li CH; Zhang YL; Bian YH; Ma L; Ge QL; Teng YC; Zhang ZG
    Int J Clin Exp Pathol; 2014; 7(5):2068-78. PubMed ID: 24966915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.
    Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA
    Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrioid endometrial carcinomas with microcystic, elongated, and fragmented (MELF) type of myoinvasion: role of immunohistochemistry in the detection of occult lymph node metastases and their clinical significance.
    Espinosa I; Serrat N; Zannoni GF; Rovira R; D'Angelo E; Prat J
    Hum Pathol; 2017 Dec; 70():6-13. PubMed ID: 28601659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression analysis of URI/RMP gene in endometrioid adenocarcinoma by tissue microarray immunohistochemistry.
    Gu J; Liang Y; Qiao L; Li X; Li X; Lu Y; Zheng Q
    Int J Clin Exp Pathol; 2013; 6(11):2396-403. PubMed ID: 24228101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of ephrinB2 and EphB4 in tumor advancement of uterine endometrial cancers.
    Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
    Ann Oncol; 2007 Mar; 18(3):485-90. PubMed ID: 17108150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.